Skip to content

The Efect of Azithromicyn on Bronchopulmonary Displasia in Extremely Preterm and Very Preterm Infant

The Efect of Azithromicyn on Bronchopulmonary Displasia in Extremely Preterm and Very Preterm Infant

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05311228
Enrollment
120
Registered
2022-04-05
Start date
2021-06-08
Completion date
2022-04-01
Last updated
2024-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmonary Dysplasia, Intraventricular Hemorrhage, Necrotizing Enterocolitis

Brief summary

This study was to see the effectiveness of azithromycin in preventing the incidence of bronchopulmonary dysphasia in extremely preterm and very premature infants. Inclusion criteria were infants with a gestational age of 25-31 weeks 6 days who experienced respiratory distress and their families had agreed to participate in the study, then randomized. The intervention was in the form of giving azithromycin in the intervention group and no intervention was carried out in the control group and then followed up to 36 weeks PMA

Interventions

Azithromicyn intravena for 14 days

Sponsors

Indonesia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Two groups, one group intervention and one group control

Eligibility

Sex/Gender
ALL
Age
25 Weeks to 32 Weeks
Healthy volunteers
No

Inclusion criteria

* premature infant 25-31 weeks 6 days with respiratory distress,

Exclusion criteria

* multiple congenital anomaly

Design outcomes

Primary

MeasureTime frameDescription
Bronchopulmonaty DysplasiaBPD mild room air until 36 weeks PMA, BPD moderate use of oxygen <30% until 36 weeks PMA, BPD severe use of oxygen >30% until 36 weeks PMAUse of oxygen suplemantation at least 28 days until 36 weeks PMA

Secondary

MeasureTime frameDescription
Intraventricular hemorrhage1 days-7 days, and 6 weeksSign of IVH from head ultrasonography from USG we can found the sign of IVH grade 1 if we perform head USG and we found bleeding in germinal matriks grade 2 if we perform head USG and we found bleeding intaventricular without ventricle dilatation grade 3 if we perform head USG we found bleeding intraventrucular with dilatation of ventricle grade 4 if we perform head USG and we found bleeding in parenchime Head USG perform at 1-7 days and then in 6 weeks
Necrotizing Enterocolitis1 days-36 weeks PMASign and symptoms of NEC from clinical, laboratory, and radiology If we found : From clinical sign : temperature \< 36.5 degree C or \> 37.5 degree C, Respiratory rate \> 60/min with retraction, abdominal distention Laboratory examination : trombocyte \< 100.000/mm3, natrium \<135 meq/L, pH \< 7.1, BE \> -12, CRP \> 5 IU Radiology examination : sign of pneumatosis intestinalis NEC : clinically + laboratory + radiology

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026